deltatrials
Completed PHASE2 NCT02323373

Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty

Topical Versus Intravenous Tranexamic Acid in Total Knee Arthroplasty: a Randomized Clinical Trial With 90 Patients

Sponsor: Irmandade da Santa Casa de Misericordia de Sao Paulo

Conditions Arthrosis
Interventions Placebo Tranexamic Acid - intravenous Tranexamic Acid - topical
Updated 5 times since 2017 Last updated: Jan 12, 2015 Started: Jun 30, 2014 Primary completion: Nov 30, 2014 Completion: Nov 30, 2014

Listed as NCT02323373, this PHASE2 trial focuses on Arthrosis and remains completed. Sponsored by Irmandade da Santa Casa de Misericordia de Sao Paulo, it has been updated 5 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Irmandade da Santa Casa de Misericordia de Sao Paulo
Data source: Irmandade da Santa Casa de Misericordia de Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.